DE60235809D1 - Nukleinsäurefreie ghost zusammensetzungen - Google Patents

Nukleinsäurefreie ghost zusammensetzungen

Info

Publication number
DE60235809D1
DE60235809D1 DE60235809T DE60235809T DE60235809D1 DE 60235809 D1 DE60235809 D1 DE 60235809D1 DE 60235809 T DE60235809 T DE 60235809T DE 60235809 T DE60235809 T DE 60235809T DE 60235809 D1 DE60235809 D1 DE 60235809D1
Authority
DE
Germany
Prior art keywords
compositions
nucleic acid
free ghost
ghost
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235809T
Other languages
English (en)
Inventor
Werner Lubitz
Wolfgang Haidinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60235809D1 publication Critical patent/DE60235809D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE60235809T 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen Expired - Lifetime DE60235809D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30459501P 2001-07-11 2001-07-11
PCT/EP2002/007758 WO2003006630A2 (en) 2001-07-11 2002-07-11 Nucleic acid free ghost preparations

Publications (1)

Publication Number Publication Date
DE60235809D1 true DE60235809D1 (de) 2010-05-12

Family

ID=23177160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235809T Expired - Lifetime DE60235809D1 (de) 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen

Country Status (8)

Country Link
US (1) US7399476B2 (de)
EP (1) EP1404808B1 (de)
AT (1) ATE462779T1 (de)
AU (1) AU2002328340B2 (de)
CA (1) CA2453518C (de)
DE (1) DE60235809D1 (de)
NZ (1) NZ530780A (de)
WO (1) WO2003006630A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
CA2710814C (en) 2008-01-18 2014-10-14 Werner Lubitz Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
ES2525205T3 (es) 2011-11-09 2014-12-18 Werner Lubitz Vacuna para su uso en inmunoterapia tumoral
EP3195878A1 (de) 2016-01-22 2017-07-26 Werner Lubitz Bakterielle ghosts zur behandlung von krebs
US11547662B2 (en) 2017-10-25 2023-01-10 Allero Therapeutics B.V. Treatment of immune diseases by administration of antigen-specific formulations
CN112410360A (zh) * 2021-01-18 2021-02-26 西南大学 一种鸡病原细菌菌影及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
WO1995010614A1 (en) * 1993-10-13 1995-04-20 Gx Biosystems A/S Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms

Also Published As

Publication number Publication date
CA2453518C (en) 2010-02-02
EP1404808A2 (de) 2004-04-07
US20040213810A1 (en) 2004-10-28
WO2003006630A2 (en) 2003-01-23
CA2453518A1 (en) 2003-01-23
NZ530780A (en) 2005-06-24
EP1404808B1 (de) 2010-03-31
US7399476B2 (en) 2008-07-15
AU2002328340B2 (en) 2007-06-28
ATE462779T1 (de) 2010-04-15
WO2003006630A3 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
IL233223A0 (en) Pharmaceutical preparations and diagnostic preparations containing corresponding nucleic acids and proteins known as p1g3282
ITRM980103A0 (it) Uso di batteri dotati di arginina deiminasi per introdurre apostosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
WO2008057529A3 (en) Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
BR0010721A (pt) Composições de neisserias combinadas
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DK1458760T3 (da) Indfangede bindingsproteiner som biosensorer
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
NO20055838D0 (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
DE60218998D1 (de) Auf Bläschen basierendes Impfstoff gegen Chlamydia
BR0207394A (pt) Proteìna de fusão para a secreção de uma proteìna de interesse no sobrenadante da cultura bacteriana
WO2002024883A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
DE60235809D1 (de) Nukleinsäurefreie ghost zusammensetzungen
ATE418070T1 (de) Dekodierung von matrixsensoren mit mikrokugeln
IL170080A (en) Nucleic acid and protein known as 158p1d7 and their pharmaceutical preparations
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
IT1270618B (it) Proteine ad attivita' antitumorale
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
EP2116616A3 (de) In aktivierten T-Zellen differentiell exprimierte Gene und deren Verwendungen
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
IL158860A0 (en) Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition